Impact BioMedical Inc.
IBO
$0.6437
-$0.0211-3.17%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,517.47% | -31.70% | -2,094.98% | 465.66% | 30.81% |
| Total Depreciation and Amortization | 100.00% | -50.00% | 100.00% | 100.00% | -50.00% |
| Total Amortization of Deferred Charges | 2.88% | 1.44% | -0.72% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 4,570.98% | 50.00% | 100,042.31% | -37,740.00% | 76.54% |
| Change in Net Operating Assets | 109.52% | 83.33% | -175.18% | -161.50% | -158.88% |
| Cash from Operations | -80.26% | -41.49% | -190.07% | -91.51% | 47.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -100.00% | -- | 0.00% |
| Cash from Investing | -100.00% | -- | -100.00% | 200.00% | 109.09% |
| Total Debt Issued | -- | -- | 153.02% | -74.25% | -48.53% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 153.02% | 354.02% | -48.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -68,200.00% | -234.50% | 1,246.46% | -100.00% |